Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study
Background: There is little evidence on the use of secondary prevention medicines for cardiovascular disease by socioeconomic groups in countries at different levels of economic development. Methods: We assessed use of antiplatelet, cholesterol, and blood-pressure-lowering drugs in 8492 individuals...
出版年: | The Lancet Global Health |
---|---|
第一著者: | |
フォーマット: | 論文 |
言語: | English |
出版事項: |
Elsevier Ltd
2018
|
オンライン・アクセス: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044636388&doi=10.1016%2fS2214-109X%2818%2930031-7&partnerID=40&md5=8cb7bd9c36760fe13fa43d671fe8120d |